Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.

Anna Nordlander,Michael Uhlin,Olle Ringdén,Gunilla Kumlien,Dan Hauzenberger,Jonas Mattsson

Transplant Immunology（2011）

引用 26|浏览10

暂无评分

摘要

It has been shown that antibodies to donor CD34+/VEGFR-2+ stem cells or antibodies against mismatched HLA are associated with graft rejection after hematopoietic stem cell transplantation (HSCT). CD34/VEGFR-2 positive stem cells have been implicated to play a major role in engraftment after HSCT.

查看译文

关键词

Allogeneic stem cell transplantation,Rituximab,Rejection

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要